Na Li et al. observed that deleting the N6-methylation of adenosine (m6A) demethylase Alkbh5 sensitized tumors to cancer immunotherapy in well-established ICB mouse cancer models (Lia et al., 2020). The gene discussed is ALKBH5; the disease is cancer.